美国Nanosphere, Inc
Nanosphere公司位于伊力诺依州，生产能够进行分子诊断测试的系统。今年早些时候，这套系统得以应用来衡量病人血块的凝结，以及一个病人如何通过新陈代谢；来应对血块的凝结。同时这家公司也在为癌症、囊肿性纤维化基因突变、疱疹感染等疾病进行实验。

Nanosphere, Inc. is a nanotechnology-based healthcare company, offering proprietary breakthrough technologies that provide a unique and powerful solution to greatly simplify diagnostic testing.
Nanosphere was founded in the year 2000 based upon nanotechnology discoveries at Northwestern University in Evanston, Illinois by Dr. Robert Letsinger and Dr. Chad Mirkin. Among other achievements, these discoveries made possible the consistent manufacturing and functionalization of gold nanoparticles with oligonucleotides (DNA or RNA), or antibodies that can be used in diagnostic applications to detect nucleic acid or protein targets, respectively.

Since its founding, Nanosphere has made continuous enhancements to the original technology advances by coupling the gold nanoparticle chemistry and capabilities with multiplex array analysis, microfluidics, and human factors instrument engineering and software development to produce a full-solution, diagnostics workstation, the Verigene® System.

The company is now a fully-integrated, healthcare company with established cGMP manufacturing operations, leading edge research and development teams, and veteran customer service and support teams.